BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kwon SY, Choe WH, Lee CH, Yeon JE, Byun KS. Rapid re-emergence of YMDD mutation of hepatitis B virus with hepatic decompensation after lamivudine retreatment. World J Gastroenterol 2008; 14(27): 4416-4419 [PMID: 18666338 DOI: 10.3748/wjg.14.4416]
URL: https://www.wjgnet.com/1007-9327/full/v14/i27/4416.htm
Number Citing Articles
1
Mariko Kobayashi, Fumitaka Suzuki, Norio Akuta, Hiromi Yatsuji, Tetsuya Hosaka, Hitomi Sezaki, Masahiro Kobayashi, Yusuke Kawamura, Yoshiyuki Suzuki, Yasuji Arase, Kenji Ikeda, Rie Mineta, Satomi Iwasaki, Sachiyo Watahiki, Hiromitsu Kumada. Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatmentHepatology Research 2010; 40(2): 125 doi: 10.1111/j.1872-034X.2009.00565.x
2
G Brook, J Main, M Nelson, S Bhagani, E Wilkins, C Leen, M Fisher, Y Gilleece, R Gilson, A Freedman, R Kulasegaram, K Agarwal, C Sabin, C Deacon‐Adams. British HIV Association guidelines for the management of coinfection with HIV‐1 and hepatitis B or C virus 2010HIV Medicine 2010; 11(1): 1 doi: 10.1111/j.1468-1293.2009.00781.x
3
Guang-Wen Cao. Clinical relevance and public health significance of hepatitis B virus genomic variationsWorld Journal of Gastroenterology 2009; 15(46): 5761-5769 doi: 10.3748/wjg.15.5761
4
Jordan J. Feld, Lisette A. P. Krassenburg. What Comes First: Treatment of Viral Hepatitis or Liver Cancer?Digestive Diseases and Sciences 2019; 64(4): 1041 doi: 10.1007/s10620-019-05518-5
5
Klaus Meyer, Per Magne Ueland. Advances in Clinical Chemistry 2011; 53: 1 doi: 10.1016/B978-0-12-385855-9.00001-1